科指回吐2.5%略失6,200 美團/比亞迪電子/快手挫4%-6%
南非出現較Delta更具傳染力的新變種病毒株(B.1.1.529),市場憂慮環球爆發新一輪疫情,美股期貨全面下跌,道指期貨最多急跌418點或近1.2%低見35,331,現報35,371,挫378點或近1.1%;納指一百期貨低見16,255,現報16,304,回吐0.4%。亞太區股市除越南續升0.6%屢創紀錄高外,無一倖免,尤其是日經午後跌幅進一步擴至837點或2.8%報28,661;星台韓、澳紐及港股跌逾1%-2%,恆指最傷曾低見24,192,現報24,230,急跌509點或近2.1%。
本港恆生科技指數繼昨天七個交易日來首彈後,今早再度下挫,最低見6,194,現報6,199,挫159點或2.5%。
30隻科指成份股普遍跌逾1%-2%;重磅新經濟股阿里巴巴(09988.HK)、騰訊(00700.HK)及美團(03690.HK)跌幅更擴至3%-4%,分別低見131.3元、460元及261.8元,後者股價失守50天線(266.3元)。
比亞迪電子(00285.HK)回吐4.5%報32.55元,股價失守百天線(33.65元)。舜宇(02382.HK)及瑞聲(02018.HK)低見227元及34.8元,現報228.2元及34.9元,跌3.8%及3.1%。
快手(01024.HK)反彈未能企穩「紅底股」,掉頭連跌第二天,今早股價失守20天及10天線後,沽壓湧現,最低見91.5元,現報92.1元,續挫5.9%為最傷成份股。
中績轉蝕2.32億人民幣遭多間外資行削價的阿里健康(00241.HK)八連跌,最低見7.4元屢創逾兩年低,現報7.45元,續跌4.2%。平安好醫生(01833.HK)也跌3.2%報30.45元。然而,海爾智家(06690.HK)逆彈2%報29.65元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.